Market's view on Conygar Inv
Published on April 2024
- Concerns raised about a £5m fundraising where £1m was spent on expenses, netting only £4m.
- General skepticism towards share buybacks, except in cases where private equity funds trade at a significant discount.
- Critique of recent costly debt decisions by a company, questioning the wisdom of past share buybacks which led to reliance on expensive borrowing.
- Discussion on the lack of market for a 693-student residence, with no buyers and potential impact on share price following upcoming results.
- Discussion about a company rated as a recovery buy, despite previous indications it was a good opportunity to lose money.
- Alarm expressed at a 30% drop in NAV, highlighting market challenges.
- Comments on a company’s trading well below its NAV and issues with its online presence.
- Details about a new ZDP issue listed on The International Stock Exchange.
- Discussion on a company’s ZDP issue with a 9% GRY, raising concerns about the cost of capital.
- Questions raised about the strategic land holdings of a company in relation to potential government nuclear strategies.
- Observations linking cessation of board postings to price recovery.
- Criticism of a company’s board for high remuneration packages possibly not aligned with shareholder interests.
- Interest in a company due to no debt and a 25% discount to net assets, and speculation about potential acquisition by larger companies.
- Concerns about the impact of COVID-19 on property values and the future of the property market amidst Brexit uncertainties.